Pfizer and Moderna asked regulators to greenlight fourth doses of Covid vaccine amid reports of waning immunity and ahead of an anticipated uptick in omicron cases.
Pfizer and Moderna asked regulators to greenlight fourth doses of Covid vaccine amid reports of waning immunity and ahead of an anticipated uptick in omicron cases.